505 related articles for article (PubMed ID: 23694989)
1. Nutrient regulation of the mTOR complex 1 signaling pathway.
Kim SG; Buel GR; Blenis J
Mol Cells; 2013 Jun; 35(6):463-73. PubMed ID: 23694989
[TBL] [Abstract][Full Text] [Related]
2. Nutrient signaling to mTOR and cell growth.
Jewell JL; Guan KL
Trends Biochem Sci; 2013 May; 38(5):233-42. PubMed ID: 23465396
[TBL] [Abstract][Full Text] [Related]
3. Spatial regulation of the mTORC1 system in amino acids sensing pathway.
Suzuki T; Inoki K
Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):671-9. PubMed ID: 21785113
[TBL] [Abstract][Full Text] [Related]
4. Growing knowledge of the mTOR signaling network.
Huang K; Fingar DC
Semin Cell Dev Biol; 2014 Dec; 36():79-90. PubMed ID: 25242279
[TBL] [Abstract][Full Text] [Related]
5. mTOR-dependent cell survival mechanisms.
Hung CM; Garcia-Haro L; Sparks CA; Guertin DA
Cold Spring Harb Perspect Biol; 2012 Dec; 4(12):. PubMed ID: 23124837
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic target of rapamycin: integrating growth factor and nutrient signaling in the collecting duct.
Brown AL; Fluitt MB; Ecelbarger CM
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F413-F416. PubMed ID: 29846113
[TBL] [Abstract][Full Text] [Related]
7. Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism.
Chen CH; Kiyan V; Zhylkibayev AA; Kazyken D; Bulgakova O; Page KE; Bersimbaev RI; Spooner E; Sarbassov DD
J Biol Chem; 2013 Sep; 288(38):27019-27030. PubMed ID: 23928304
[TBL] [Abstract][Full Text] [Related]
8. Current models of mammalian target of rapamycin complex 1 (mTORC1) activation by growth factors and amino acids.
Zheng X; Liang Y; He Q; Yao R; Bao W; Bao L; Wang Y; Wang Z
Int J Mol Sci; 2014 Nov; 15(11):20753-69. PubMed ID: 25402640
[TBL] [Abstract][Full Text] [Related]
9. Multiple amino acid sensing inputs to mTORC1.
Shimobayashi M; Hall MN
Cell Res; 2016 Jan; 26(1):7-20. PubMed ID: 26658722
[TBL] [Abstract][Full Text] [Related]
10. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic mTOR: the rookie energy sensor.
Martínez de Morentin PB; Martinez-Sanchez N; Roa J; Ferno J; Nogueiras R; Tena-Sempere M; Dieguez C; Lopez M
Curr Mol Med; 2014 Jan; 14(1):3-21. PubMed ID: 24236459
[TBL] [Abstract][Full Text] [Related]
12. Amino acids and mTORC1: from lysosomes to disease.
Efeyan A; Zoncu R; Sabatini DM
Trends Mol Med; 2012 Sep; 18(9):524-33. PubMed ID: 22749019
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic Target of Rapamycin Complex 1: From a Nutrient Sensor to a Key Regulator of Metabolism and Health.
Wang G; Chen L; Qin S; Zhang T; Yao J; Yi Y; Deng L
Adv Nutr; 2022 Oct; 13(5):1882-1900. PubMed ID: 35561748
[TBL] [Abstract][Full Text] [Related]
14. SLC38A9: A lysosomal amino acid transporter at the core of the amino acid-sensing machinery that controls MTORC1.
Rebsamen M; Superti-Furga G
Autophagy; 2016 Jun; 12(6):1061-2. PubMed ID: 26431368
[TBL] [Abstract][Full Text] [Related]
15. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output.
Dibble CC; Manning BD
Nat Cell Biol; 2013 Jun; 15(6):555-64. PubMed ID: 23728461
[TBL] [Abstract][Full Text] [Related]
16. mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action.
Soliman GA; Acosta-Jaquez HA; Dunlop EA; Ekim B; Maj NE; Tee AR; Fingar DC
J Biol Chem; 2010 Mar; 285(11):7866-79. PubMed ID: 20022946
[TBL] [Abstract][Full Text] [Related]
17. Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing.
Carroll B; Nelson G; Rabanal-Ruiz Y; Kucheryavenko O; Dunhill-Turner NA; Chesterman CC; Zahari Q; Zhang T; Conduit SE; Mitchell CA; Maddocks ODK; Lovat P; von Zglinicki T; Korolchuk VI
J Cell Biol; 2017 Jul; 216(7):1949-1957. PubMed ID: 28566325
[TBL] [Abstract][Full Text] [Related]
18. Genetic and pharmacologic evidence that mTOR targeting outweighs mTORC1 inhibition as an antimyeloma strategy.
Chen X; Díaz-Rodríguez E; Ocio EM; Paiva B; Mortensen DS; Lopez-Girona A; Chopra R; Miguel JS; Pandiella A
Mol Cancer Ther; 2014 Feb; 13(2):504-16. PubMed ID: 24431075
[TBL] [Abstract][Full Text] [Related]
19. Loss of mTOR signaling affects cone function, cone structure and expression of cone specific proteins without affecting cone survival.
Ma S; Venkatesh A; Langellotto F; Le YZ; Hall MN; Rüegg MA; Punzo C
Exp Eye Res; 2015 Jun; 135():1-13. PubMed ID: 25887293
[TBL] [Abstract][Full Text] [Related]
20. Amino acid signalling upstream of mTOR.
Jewell JL; Russell RC; Guan KL
Nat Rev Mol Cell Biol; 2013 Mar; 14(3):133-9. PubMed ID: 23361334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
